Recent News

By Category: Countermeasures

HHS replenishes nation’s supply of anthrax antitoxin

(HHS) The nation’s supply of anthrax antitoxin will be maintained until 2018 under Project BioShield contracts issued by the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR). Orders placed today will replenish the stockpile of anthrax antitoxin as doses currently in the Strategic National Stockpile expire. Read More »

September 20, 2013
| Filed under North America and Countermeasures
Share

Two new versions of the flu vaccine arriving soon

(ScienceDaily) For the first time, there will be a vaccine which protects against four strains of the flu virus. Until now, flu vaccines have only protected against three forms of the virus. Each year, scientists choose what they believe will be the three most common forms of the flu to spread during the winter months, Read More »

September 4, 2013
| Filed under North America, South America, and Countermeasures
Share

Experimental Ebola treatment protects some primates even after disease symptoms appear

(EurekAlert) Scientists have successfully treated the deadly Ebola virus in infected animals following onset of disease symptoms, according to a report published online today in Science Translational Medicine. The results show promise for developing therapies against the virus, which causes hemorrhagic fever with human case fatality rates as high as 90 percent. According to first Read More »

August 22, 2013
| Filed under Africa, North America, South America, Agents & Toxins, Countermeasures, and Research
Share

Salk Institute Findings May Lead to New Broad-Spectrum Antivirals

(GlobalBiodefense) Researchers at the Salk Institute for Biological Studies have discovered a powerful mechanism by which viruses such as influenza, West Nile and Dengue evade the body’s immune response and infect humans with these potentially deadly diseases. The findings may provide scientists with an attractive target for novel antiviral therapies. Published in the August issue Read More »

August 20, 2013
| Filed under Europe, North America, South America, Countermeasures, and Research
Share

Investigational Malaria Vaccine Found Safe and Protective

(NIH) An investigational malaria vaccine has been found to be safe, to generate an immune system response, and to offer protection against malaria infection in healthy adults, according to the results of an early-stage clinical trial published Aug. 8 in the journal Science. The vaccine, known as PfSPZ Vaccine, was developed by scientists at Sanaria Read More »